Veeva Systems (NYSE:VEEV) has reported its fiscal 2026 second-quarter financial results. The company, operating in the life sciences industry, announced revenue figures and non-GAAP earnings. Positive growth figures (e.g., 17% increase in revenue) indicate strong performance. Veeva’s focus on AI and data cloud solutions within the healthcare sector suggests its alignment with industry trends. Investors in the healthcare technology space should find these results encouraging, pointing to continued growth and innovation for Veeva.